Glenmark Pharma

Glenmark Pharma Posted Revenue Growth of 12.4 % in FY 2021-22

Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company, today announced its financial results for the fourth quarter ended March 31, 2022.

By SMEStreet Edit Desk

May 30, 2022 06:15 IST logo

4 Min read

Global

Glenmark Pharma Gets ANDA approval for Lacosamide Tablets USP

By SMEStreet Edit Desk

Mar 21, 2022 08:08 IST logo

2 Min read

Glenn Saldahna, Stock Market, BSE, Glenmark Pharmaceuticals, USFDA, Acid Reflux

Sectors

Glenmark Commences 1000 Patients Surveillance Study with COVID-19 for FabiFlu

By SMEStreet Desk

Jul 13, 2020 11:59 IST logo

3 Min read

News

COVID-19 Drug By Glenmark Set for Market at Rs 103 Per Tablet After Getting DCGI Approval

By SMEStreet Desk

Jun 20, 2020 15:22 IST logo

3 Min read

LimeLight

DGCA Allows Glenmark Pharma For Clinical Trials of Favipiravir Tablets on COVID-19 Patients

By SMEStreet Edit Desk

May 01, 2020 04:56 IST logo

2 Min read

News

Glenmark Pharma Rises 3% on USFDA Approval for Monroe Facility

By SMEStreet Desk

Jun 19, 2018 06:03 IST logo

1 Min read